These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 9163302)
1. High-dose chemotherapy for breast cancer. de Vries EG; Mastenbroek CC; Rodenhuis S Ann Intern Med; 1997 Jun; 126(11):917-8. PubMed ID: 9163302 [No Abstract] [Full Text] [Related]
2. High-dose chemotherapy for primary breast cancer: facts versus anecdotes. Hortobagyi GN J Clin Oncol; 1999 Nov; 17(11 Suppl):25-9. PubMed ID: 10630258 [No Abstract] [Full Text] [Related]
3. Critique of the high-dose chemotherapy studies in breast cancer: a positive look at the data. Antman KH J Clin Oncol; 1999 Nov; 17(11 Suppl):30-4. PubMed ID: 10630259 [No Abstract] [Full Text] [Related]
4. Dose-dense chemotherapy for breast cancer: the story so far. Hudis C Br J Cancer; 2000 Jun; 82(12):1897-9. PubMed ID: 10864194 [No Abstract] [Full Text] [Related]
5. Are there still reasons to believe that high-dose chemotherapy has a role in breast cancer management? Castagna L; Martino M Bone Marrow Transplant; 2013 Feb; 48(2):305. PubMed ID: 22750999 [No Abstract] [Full Text] [Related]
6. A big trial for a new technology: TransBIG Project takes microarrays into clinical trials. Tuma RS J Natl Cancer Inst; 2004 May; 96(9):648-9. PubMed ID: 15126595 [No Abstract] [Full Text] [Related]
7. Chemotherapy dose and schedule in adjuvant treatment of breast cancer: phoenix, turkey, or dodo? Crown J Lancet; 2003 Aug; 362(9385):677-8. PubMed ID: 12957087 [No Abstract] [Full Text] [Related]
8. [San Antonio Breast Cancer Symposium 2003. New therapeutic prospects in the treatment of early-stage breast cancer]. Montemurro F Tumori; 2004; 90(1):suppl 1-16. PubMed ID: 15143995 [No Abstract] [Full Text] [Related]
9. Chaos surrounds high-dose chemotherapy for breast cancer. Lancet; 1999 May; 353(9165):1633. PubMed ID: 10335776 [No Abstract] [Full Text] [Related]
10. What is the role of high-dose chemotherapy in the era of targeted therapies? Hortobagyi GN J Clin Oncol; 2004 Jun; 22(12):2263-6. PubMed ID: 15111620 [No Abstract] [Full Text] [Related]
11. 'Small' randomised neo-adjuvant chemotherapy trials in breast cancer reporting on pathological response: more harm than good? Bonnefoi H Ann Oncol; 2005 Sep; 16(9):1407-10. PubMed ID: 16076932 [No Abstract] [Full Text] [Related]
13. [High-dose chemotherapy for breast cancer: are we at the end or at the end of the beginning?]. Lopez M Clin Ter; 1999; 150(4):259-62. PubMed ID: 10605161 [No Abstract] [Full Text] [Related]
14. [Dose density and dose intensity in the treatment of breast cancer]. Saintigny P; Assouad S; Gligorov J; Selle F; Roché H; Breau JL; Morère JF; Lotz JP Bull Cancer; 2004 Dec; 91 Suppl 4():S244-53. PubMed ID: 15899616 [TBL] [Abstract][Full Text] [Related]
15. Re: Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. Popat S; Smith IE J Natl Cancer Inst; 2005 Jun; 97(11):858; author reply 858-9. PubMed ID: 15928308 [No Abstract] [Full Text] [Related]
16. Dose in (adjuvant) chemotherapy of breast cancer. Nitz U Cancer Treat Res; 2009; 151():239-53. PubMed ID: 19593516 [No Abstract] [Full Text] [Related]
18. Unravelling the mystery of the TACT trial. Martin M Lancet; 2009 May; 373(9676):1662-3. PubMed ID: 19447241 [No Abstract] [Full Text] [Related]
19. The status of high-dose chemotherapy in breast cancer. Rodenhuis S Oncologist; 2000; 5(5):369-75. PubMed ID: 11040272 [TBL] [Abstract][Full Text] [Related]
20. High-dose chemotherapy for breast cancer. Rushing DA Ann Intern Med; 1997 Jun; 126(11):917; author reply 918. PubMed ID: 9163301 [No Abstract] [Full Text] [Related] [Next] [New Search]